Thyroid function and the risk of fibrosis of the liver, heart and lung in humans: A systematic review and meta-analysis.

Bano, Arjola; Chaker, Layal; Muka, Taulant; Mattace-Raso, Francesco U S; Bally, Lia; Franco, Oscar H; Peeters, Robin P; Razvi, Salman (2020). Thyroid function and the risk of fibrosis of the liver, heart and lung in humans: A systematic review and meta-analysis. Thyroid, 30(6), pp. 806-820. Mary Ann Liebert 10.1089/thy.2019.0572

[img] Text
Bano Thyroid 2020_epub.pdf - Accepted Version
Restricted to registered users only until 8 January 2021.
Available under License Publisher holds Copyright.

Download (566kB) | Request a copy

Background Fibrotic diseases have an unclear etiology and poor prognosis. Fluctuations in thyroid function may play a role in the development of fibrosis, but evidence is fragmented and inconclusive. This systematic review and meta-analysis aimed to investigate the association of thyroid function with fibrotic diseases of the liver, heart, and lung, in humans. Methods We searched Pubmed, Medline Ovid, Embase Ovid, and Web-of-Science for studies published from inception to 14 June 2019, to identify observational studies that investigated the association of thyroid function with fibrosis of the liver, heart, and lung, in humans. Study quality was evaluated by Newcastle-Ottawa Scale. The Mantel-Haenszel method was used to pool the odds ratios (ORs) of studies investigating the association of hypothyroidism with liver fibrosis. Results Out of 2196 identified articles, 18 studies were included in the systematic review, of which 11 studies reported on liver fibrosis, 4 on myocardial fibrosis, and 3 on pulmonary fibrosis. The population sample size ranged from 36 to 7259 subjects, with median mean age 51 years (range, 36-69) and median percentage of women 53 (range, 17-100). The risk of bias of studies was low to moderate to high. Higher serum thyrotropin and lower thyroid hormone levels were generally associated with higher likelihood of fibrosis. Compared to euthyroidism, overt and subclinical hypothyroidism were associated with a higher likelihood of fibrosis in the liver (6 of 7 studies), heart (3 of 3 studies), and lung (3 of 3 studies). Based on the results of the 7 studies included in the meta-analysis, overt and subclinical hypothyroidism were associated with an increased risk of liver fibrosis (pooled OR, 2.81; 95% confidence interval [CI], 1.74-4.53; heterogeneity, I2 31.4%; pooled OR, 2.12; CI, 1.45-3.12, heterogeneity, I2 0% respectively), without evidence of publication bias. Conclusions This study suggests that low thyroid function is associated with increased likelihood of chronic fibrotic diseases of the liver, heart, and lung. However, the evidence is mainly based on cross-sectional data. Prospective studies and randomized clinical trials are needed to investigate the potential efficacy of thyroid hormone and its analogues on the occurrence and progression of fibrosis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Bano, Arjola; Muka, Taulant; Bally, Lia Claudia and Franco Duran, Oscar Horacio

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1050-7256

Publisher:

Mary Ann Liebert

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

15 Jan 2020 17:24

Last Modified:

11 Jun 2020 01:33

Publisher DOI:

10.1089/thy.2019.0572

PubMed ID:

31910097

BORIS DOI:

10.7892/boris.138788

URI:

https://boris.unibe.ch/id/eprint/138788

Actions (login required)

Edit item Edit item
Provide Feedback